Clearmind Medicine Inc. Share Price Canadian Securities Exchange
Equities
CMND
CA1850534027
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 1.78M 2.44M 149M |
---|---|---|---|---|---|
Net income 2022 | -9M -12.31M -751M | Net income 2023 | -8M -10.94M -667M | EV / Sales 2022 | - |
Net cash position 2022 | 388K 530K 32.36M | Net cash position 2023 | 5.51M 7.54M 460M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.09
x | P/E ratio 2023 |
-0.09
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+24.35% | 44.96B | |
+1.36% | 42.65B | |
+46.11% | 41.85B | |
-4.27% | 29.04B | |
+11.28% | 26.08B | |
-20.65% | 19.03B | |
+7.00% | 12.75B | |
+28.30% | 12.06B | |
-4.08% | 11.75B |